Heltra: Explore Life – Discover More – Live Better

Scientists Found a Way to Boost Weight Loss Without Sacrificing Muscle, but There’s a Catch

Scientists at the University of California, Berkeley, have discovered a potential way to make Ozempic-style weight loss more effective without sacrificing muscle. Instead of further suppressing appetite, their experimental compound increased calorie burning by up to 18 percent in mice.

The research, published in Science Advances, found that a compound called TOFA reduced body fat without significant lean-mass loss. It also enhanced the effects of semaglutide and tirzepatide in combination experiments. The catch? Nobody knows whether it works safely in humans.

Related: Scientists Found an Inherited Prostate Cancer Risk That Struck Men as Young as 44

Next: Wegovy Users Lost Weight, but Something Surprising Happened to Their Muscle

Scientists Found Another Way to Burn Calories

Most popular weight-loss medications help people eat less. Berkeley researchers wanted to investigate the other side of the equation: making the body expend more energy.

Advertisement

Advertisement

“Body weight responds to two levers: taking in fewer calories, or spending more energy,” said Anders Näär, Ph.D., professor of metabolic biology and nutrition at UC Berkeley. “GLP-1s work almost entirely on the first, so we went after the second.”

TOFA works by interfering with fatty-acid production while activating cellular pathways involved in burning fat.

According to the university’s research report, treated mice showed improved insulin sensitivity, lower triglycerides, and reduced liver fat.

Not bad for a compound first discovered in the 1970s.

Next: Scientists Tested 3 Workouts for Adults Over 65 and One Result Surprised Researchers

Why Ozempic Users Should Pay Attention

Losing weight isn’t necessarily the same as improving body composition. Some people taking GLP-1 medications lose lean tissue alongside fat.

Advertisement

Advertisement

Berkeley’s findings suggest a future treatment might address that trade-off while improving metabolic health.

“In our combination experiments, TOFA worked additively or synergistically with the GLP-1 appetite-suppressing drugs, so we view it as complementary rather than as a replacement,” Näär said.

That distinction matters. Researchers aren’t proposing another appetite suppressant. They’re investigating whether two different metabolic approaches could work together.

Next: Scientists Uncover a Hidden Health Risk for People Taking Wegovy and Mounjaro

The Catch Behind the Promising Results

TOFA remains experimental. Researchers haven’t established its safety, effectiveness, or appropriate dosage in humans. The findings don’t justify taking the compound or changing prescribed medications.

Advertisement

Advertisement

For now, maintaining muscle during weight loss still means prioritizing resistance training, adequate protein, and medical guidance.

The takeaway: The next advance in obesity treatment may involve burning more energy rather than simply eating less. But until human trials establish meaningful benefits, your dumbbells aren’t getting replaced by a miracle pill.

Next: Stanford Scientists Found a Possible Ozempic Rival With an Unexpected Benefit

Related: Simple Heart-Healthy Habits Could Protect Your Memory After Age 60

This story was originally published by Men’s Journal on Nov 21, 2026, where it first appeared in the Health section. Add Men’s Journal as a Preferred Source by clicking here.

Source link

ADVERTISEMENT